Novo Nordisk A/S ADR buy Kepler Capital Markets
Start price
13.03.25
/
50%
€71.00
Target price
13.03.26
-
Performance (%)
-52.68%
End price
14.03.26
€33.60
Summary
This prediction ended on 14.03.26 with a price of €33.60. The BUY prediction by Kepler_Capital_Marke for Novo Nordisk A/S ADR performed very badly with a performance of -52.68%. A total of €1.10 was paid as dividends for this prediction. Kepler_Capital_Marke has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novo Nordisk A/S ADR | -4.657% | -4.657% | -41.323% |
| iShares Core DAX® | -1,86 % | 0,67 % | 0,92 % |
| iShares Nasdaq 100 | -3,32 % | 4,99 % | 33,72 % |
| iShares Nikkei 225® | -2,30 % | 6,13 % | 52,96 % |
| iShares S&P 500 | -1,31 % | 3,40 % | 24,67 % |
Comments by Kepler_Capital_Marke for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) was upgraded by analysts at Kepler Capital Markets from a "hold" rating to a "buy" rating.
Ratings data for NVO provided by MarketBeat
In the thread Trading Novo Nordisk A/S ADR
Die von Kepler_Capital_Marke gewählte maximale Laufzeit wurde überschritten